- Stereotaxis to acquire cardiovascular robotics company for $45M
- Physician specialties with highest, lowest burnout rates: AMA
- Trump nominates CDC director
- Meritus Health adds Dr. Christine Lewis
- Parkland Health adds 2 inpatient units, 112 beds
- Atrium Health inks naming rights deal for Panthers training site
- What’s the deal with insurer mental health parity violations?
- Drugmaker recalls Xanax over quality issue
- NYU Langone Health opens 12K-square-foot ambulatory location
- 10 anesthesia leadership appointments from Q1
- What could improve physician market competition
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Beyond March Madness: Athletics boost academic health system marketing
- Sheppard Pratt gets $16.5M for behavioral health expansion
- How ESOPs can help retiring physicians cash out
- Specialty1 Partners’ growth in 2026: 5 updates
- North Carolina system invests $200M in cancer care
- UnityPoint Health to transition dental services to FQHC
- The ownership opportunity ASCs are leaving behind
- New York hospital taps ambulatory operations leader
- 10 trends in behavioral health usage: Report
- How hospitals are winning — and losing — the ASC moment
- 4 DSOs adding new technology
- Hawaii system names interim CEO
- Aspen Dental opens Michigan office
- Turning Fragmented Clinical Data into Actionable Insight
- Ascension taps president for 2 Texas hospitals
- Studies reaffirm fluoride safety, benefits: 10 things to know
- Philips earns FDA clearance for spectral CT with cardiac imaging
- New Oklahoma law closes dental insurer price fixing loophole
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- Air Pollution and Weather Tied to Migraines
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- Kentucky approves changes to Dental Practice Act
- Former Utah dentist accused of practicing dentistry without a license
- 7 dental companies gaining new funding
- Heartland Dental adds Michigan practice
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- ‘Mini specialists’: 5 models reshaping behavioral health in primary care
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Chicago hospital expands outpatient, walk-in mental health services
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Bill would force payers to apply DTC drug purchases to patient deductibles
- 43 states have mental health insurance disparities: 4 trends
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- The new playbook for clinician well-being
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- Anthem, Mount Sinai reach contract agreement, restore in-network coverage
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Stanford Health Care, Alameda Health System partner to support St. Rose Hospital
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Los estados se enfrentan a otro reto con las nuevas reglas laborales de Medicaid: la falta de personal
- States Change Custody Laws To Keep Children of Detained Immigrants Out of Foster Care
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Wavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platform
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
- Statement Regarding Staff No-Action Letter to Bank of England
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- Blackstone and TPG Complete Acquisition of Hologic; Names New CEO
- Blackstone and TPG Complete Acquisition of Hologic; Names New CEO
Michigan's official vaccine stance was never in doubt, but those who like details will enjoy today's MDHHS Press Release.
I've highlighted the core argument in bold font.
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2025/09/19/standing-rec
State’s Chief Medical Executive Dr. Natasha Bagdasarian makes Standing Recommendation on COVID-19 vaccines
Determines not receiving a dose of COVID-19 vaccine to be an underlying conditionLANSING, Mich. - In response to Gov. Gretchen Whitmer’s Executive Directive to state agencies to ensure Michigan families can access COVID-19 vaccines, the state’s Chief Medical Executive Dr. Natasha Bagdasarian has issued a Standing Recommendation for the COVID-19 vaccine.
“National medical organizations and scientific experts continue to recommend routine COVID-19 vaccination for those at high risk, but also recommend vaccines be made available for all those who want them, ages six months and older,” said Bagdasarian. “COVID-19 vaccines have been proven to reduce the likelihood of emergency department or urgent care visits, as well as hospitalizations and severe outcomes. They are one of our best defenses against the virus. As the state’s chief medical executive, it is my duty to protect and promote public health, and everyone deserves the opportunity to access COVID-19 vaccine if they desire one. This Standing Recommendation will help to protect vaccine accessibility and availability in our state.”
On Wednesday, Aug. 27, the U.S. Food and Drug Administration (FDA) approved the 2025-2026 vaccine for those 65 years of age and older and those ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. However, the FDA did not define the list of underlying conditions. The Centers for Disease Control and Prevention’s list includes conditions such as obesity and physical inactivity and states it is “not exhaustive” and “should not be used to exclude people with underlying conditions from recommended measures for prevention or treatment of COVID-19.”
In her recommendation, Bagdasarian stated, “Any person over the age of six months without contraindication who has not received a dose of a Food and Drug Administration (FDA)-approved or -authorized 2025-2026 COVID-19 vaccine may be considered to have an underlying condition that puts them at high risk for severe outcomes from COVID-19 and is thus eligible to receive an age-appropriate dose.”
The Michigan Department of Health and Human Services (MDHHS) continues to recommend the COVID-19 vaccine in alignment with the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.
To help ensure insurance coverage and availability of COVID-19 vaccines as outlined in the Executive Directive, MDHHS is working with the Department of Insurance and Financial Services and the Michigan Department of Licensing and Regulatory Affairs.
To learn more about COVID-19 and seasonal respiratory illnesses and how to protect yourself, visit Michigan.gov/COVIDFluRSV.
# # #
In the game of governments and vaccine policy, looks like the ball is back in the Trump Administration's court. Any bets on Medicaid funding playing a major role?
LARA just issued the same presser under the subject line, "Sharing on behalf of MDHHS."
No other comment, but an early signal to every licensed health professional in Michigan that compliance is expected.
Also Friday, the CDC's recommendation changed.
My favorite part: "shared clinical decision-making." ❤️ 🥂
Close second: MedPage again referencing "pregnant women." 😊
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/117567
CDC Panel Stops Endorsing COVID Shots, Pushes for 'Choice'
— RFK Jr.'s committee breaks from flu shot model, leaves it up to individuals to decide
by Terrence Rudd, Staff Writer, MedPage Today
September 19, 2025The CDC's vaccine advisory committee is no longer recommending the COVID-19 shot for specific groups of Americans, but instead stressing shared clinical decision-making in its newest recommendations.
The Advisory Committee on Immunization Practices (ACIP) on Friday unanimously voted 12-0 to update its recommendations for pediatric and adult immunization schedules, but it deviated from recent FDA vaccine approval language by simply calling for "individual-based decision-making" in everyone ages 6 months and older.
For those 6 months to 64 years, this was paired with recommended language that added "an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors."
Until now, the vaccinations had been recommended as a routine step in the fall for nearly all Americans who wanted them -- just like a yearly flu vaccine.
Not everything earned unanimous support during the meeting. A motion to recommend that prescriptions be required to get a COVID vaccine led to a deadlocked 6-6 vote, with ACIP Chair Martin Kulldorff, PhD, formerly of Harvard Medical School in Boston, using his tie-breaking power to kill the proposal.
Panelists worried that the prescription proposal could cut pharmacists -- who administer more than 90% of all COVID shots but can't write prescriptions under Medicare Part B rules -- from the ranks of vaccination providers. The effects could slash access and clog primary care providers' offices, some members cautioned.
A third motion to strengthen discussions with patients about COVID vaccination risks and benefits also earned unanimous 12-0 approval. That recommendation calls for discussion of known risk factors for severe COVID outcomes, including age, prior infections, immunosuppression, and other comorbidities identified by the CDC, as well as "a discussion of the potential benefits and risks of vaccination and related uncertainties, especially those outlined in the vaccine information statement, as part of informed consent."
A fourth recommendation encouraged the CDC to promote more consistent, comprehensive informed consent processes, and to encourage the addition of descriptions of six risks and uncertainties outlined by ACIP member and COVID-19 working group chair Retsef Levi, PhD, of the Massachusetts Institute of Technology Sloan School of Management in Boston. That motion passed on an 11-1 vote.
Kulldorff emphasized that the vaccination schedule recommendations won't affect vaccine access in the Vaccines for Children Program -- the federally run program that covers vaccines for about half of children in the U.S.
Sean O'Leary, MD, of the American Academy of Pediatrics (AAP), said the panel's daylong debate involved clear efforts to "sow distrust" about vaccines and would have "real-time impacts on American children."
But he expressed relief that people could instead follow guidelines from his and other medical groups that still recommend the vaccines be available, like in prior years.
"It was a very, very strange meeting," O'Leary said.
A Festivus of Vaccine Uncertainties
In June, HHS Secretary Robert F. Kennedy Jr. sacked the 17 former members of ACIP and replaced them with members more aligned with his views. During the meeting, new members put plenty of focus on COVID vaccines' perceived unknown risks and uncertain benefits.
The discussion featured contentious topics including alleged DNA alterations by mRNA vaccines and case reports of myocarditis in vaccinated people, assertions that mRNA vaccines don't work as intended, the existence of a post-vaccination syndrome, and potential connections between the vaccines and conditions such as birth defects and cancer.
In a presentation to the panel, CDC COVID-19 workgroup member Henry Bernstein, DO, of the Zucker School of Medicine at Hofstra/Northwell in New York, delivered a stinging dissent to the panel's skeptical tone. The former ACIP member called for continued vaccination coverage for a wide range of populations, including pregnant women, children younger than 2 years, older adults, "and anyone who feels they want protection for themselves and their families."
"If we don't want to say vaccines are 'safe and effective,' well, they work!" Bernstein said.
ACIP, FDA, and Medical Organizations Sing Separate Tunes
Last month, the FDA approved updated COVID vaccines for the 2025-2026 respiratory virus season for all adults 65 and older, but limited their use in younger people and children to those with at least one condition that puts them at high risk for severe disease. Kennedy also announced in May that the CDC had dropped its recommendationopens in a new tab or window that healthy children and pregnant women get routine COVID shots.
Those moves prompted multiple medical organizations to issue their own vaccination recommendations, including the AAP, the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Physicians (AAFP), and the Society for Maternal-Fetal Medicine (SMFM). The AAP and AAFP said that all children ages 6 to 23 months should be vaccinated against COVID. ACOG, SMFM, and AAFP also recommended that women who are pregnant at any stage or lactating should get a COVID shot.
Health insurer industry group AHIP released a statement Tuesday that backs ACIP's older, broader COVID vaccination recommendations. "Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing for patients through the end of 2026," AHIP said.
On Friday, the Infectious Diseases Society of America (IDSA) again called for Kennedy to resign.
"His leadership has already put up barriers to many Americans' choice to receive the COVID vaccine," said IDSA President Tina Tan, MD, in a statement. "Now he is attacking routine childhood vaccines that have been given broadly and safely for decades, creating chaos and confusion, taking away parents' choices and putting children's lives at significant risk for severe vaccine-preventable diseases."
Typically, ACIP recommendations must be approved by the CDC director, and are not considered final until they are published in the Morbidity and Mortality Weekly Report.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















